Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens

Background The recommended reliance on 12 weeks posttreatment sustained virological response (SVR12) instead of SVR24 was validated for treatment evaluation. Aim Judging claimed concordance between SVR12 and SVR24. Patients and methods In a prospective study, 91 patients received sofosbuvir (SOF)+in...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Maha M Elsabaawy, Khalid Gameel, Heba Eldemerdash, Talaat Zakareia, Mahmoud Eltahawy, Marry Albert, Marwa Fekry, Enas Ouda, Helmy Elshazly, Ashraf Eljaky
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	SpringerOpen 2019-01-01
Rangatū:	The Egyptian Journal of Internal Medicine
Ngā marau:	svr12 svr24 hcv daas
Urunga tuihono:	http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=4;spage=495;epage=501;aulast=Elsabaawy
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!